NJ-OPEX
8.6.2022 09:02:06 CEST | Business Wire | Press release
OPEX® Corporation, a global leader in Next Generation Automation for almost 50 years, is introducing leading-edge Document and Mail Automation technology on 22 June 2022 to attendees of the Association for Intelligent Information Management (AIIM) Forum Europe in London.
OPEX’s new Gemini™ high-volume scanner is “Right-Speed™,” an unrivaled scanning capability that enables different types of documents to be scanned at different speeds without changing equipment to maximize throughput and operational efficiency.
“Gemini scans the widest range of document types, sizes and conditions—and handles them at the right speed for the job,” said Scott Maurer, President, OPEX International. “Whether documents need to be scanned at high speed, packet speed or drop feed, Gemini is the most versatile scanner available.”
With scan speeds of up to 240 pages per minute, the Gemini scanner features a dual-feeder design and the ability for continuous feeding. Its five programmable sort bins enable unique sorting capabilities and easy document handling. Other features include software configurability, scalability for the future, best-in-class service, and an ergonomic, customizable work area designed to enhance operator comfort and productivity.
Ideal for service bureaus, BPOs, government institutions, tax entities, medical records companies, insurance agencies, law firms, and a host of other industries, the Gemini scanner with “Right-Speed” technology was first unveiled in April in the U.S. during the 2022 AIIM Conference in Denver, Colorado.
“We are excited to showcase the Gemini scanner and ‘Right-Speed’ technology to customers across Europe who are looking for document automation solutions to solve their most pressing business challenges,” said Maurer. “We have been expanding our facilities, personnel and infrastructure to meet the growing automation needs of customers in Europe and around the world.”
An AIIM Forum Europe Partner, OPEX will be the only company demonstrating equipment live at the event.
In the coming months, OPEX will be able to demonstrate the Gemini scanner and “Right-Speed” technology at company facilities in Germany, France and the U.K. Customers who do not wish to travel in person can attend private webinars to learn about the Gemini scanner and the rest of OPEX’s existing Document and Mail Automation portfolio, which includes the Falcon® Series of high-volume, one-touch scanners that eliminate or significantly reduce prep time.
With generations of industry expertise, a proven track record developing first-class automation capabilities and advanced engineering, and a heritage of excellence, OPEX continuously reimagines automation technology to help clients solve their most significant business challenges today and in the future. For nearly five decades, OPEX has served as a trusted partner, collaborating closely with clients to develop customized, scalable solutions.
OPEX is vertically integrated—innovating, engineering, manufacturing, selling, and servicing all its automated solutions. This translates to the highest degree of quality equipment, reliable operations, product longevity, and an exceptional client experience.
To learn more, please visit OPEX.com .
About OPEX
OPEX Corporation
is a global leader in Next Generation Automation, providing innovative, unique solutions for warehouse, document and mail automation. With headquarters in Moorestown, NJ, USA—and facilities in Pennsauken, NJ; Plano, TX; France; Germany; Switzerland; the United Kingdom; and Australia—OPEX has more than 1,500 employees who are continuously reimagining and delivering customized, scalable technology solutions that solve the business challenges of today and in the future.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220608005195/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved24.3.2026 07:00:00 CET | Press release
Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of CHF 4.3m in 2024 to a loss of CHF 1.4m in 2025. Further key statements In September 2025, our development plan for corticorelin was validated at a meeting with the FDA, enabling Curatis to proceed toward a regulatory submission supporting a pivotal study in patients suffering from peritumoral brain edema (PTBE). In November 2025, Curatis raised CHF 1.2m to progress corticorelin. The cash position as of year end 2025 was comfortable, standing at CHF 1.9m. Recently, Curatis announced a license agreement for corticorelin for Japan with significant milestone payments. Business development and finances In 2025, product sales amounted to CHF 10.3m, while service revenue amounted to CHF 0.5m. On a full year basis, Curatis AG increased revenues in its distri
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs24.3.2026 07:00:00 CET | Press release
From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of Nemluvio® (nemolizumab) in different patient populations with moderate-to-severe atopic dermatitis, including late-breaking data in pediatric patients, and share four posters on AKLIEF® (trifarotene)1-8 Additional presentations related to Dermatological Skincare will explore how artificial intelligence can identify high-risk factors for sensitive skin and Cetaphil® in different skin types9 Data from Galderma’s Injectable Aesthetics portfolio will also show how its hyaluronic acid injectables, Restylane®, and neuromodulator, RelabotulinumtoxinA*, may address aesthetic needs across the face and décolletage10-14 A total of 22 presentations will reinforce the value of Galderma’s broad and comprehensive portfolio in meeting varied patient needs across Therapeutic Dermatology, Injectable Aesthetics and Dermatological Skincare Galderma (SIX: GALD), the pure-play dermatology category leader, wi
Avanzanite Expands French Operations and Appoints Constance Sabbagh as General Manager24.3.2026 07:00:00 CET | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, France. Following a €32 million Series A investment by MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323639110/en/ Constance Sabbagh, General Manager, France “France is essential to Avanzanite’s European vision,” said Adam Plich, Co-founder and CEO of Avanzanite. “With its leadership in rare disease policy through its National Rare Disease Plans, care networks and scientific innovation, France is one of the most significant healthcare
HJS Foundation Releases JEP Protocol & HJS Framework: The "Black Box" for AI, Enabling Verifiable Human Oversight24.3.2026 04:36:00 CET | Press release
HJS Foundation (Human Judgment Systems Foundation) today released two complementary solutions: the Judgment Event Protocol (JEP) and the Human Judgment Structure (HJS) framework. As a minimalist open standard, JEP generates tamper-proof records of AI decision accountability, just like an aircraft black box; HJS embeds human judgment logic into AI operation processes — together, they transform "human oversight" from a regulatory requirement into a verifiable technical fact, providing an optional technical solution for AI accountability. How to prove that AI decisions (such as loan approvals, medical diagnoses, border screenings, etc.) have undergone human review? JEP generates immutable audit trails of human intervention through four cryptographic primitives — Judge, Verify, Delegate, Terminate; HJS builds a controllable and accountable system to prevent risks such as AI drift and ensure that human judgment guides AI operations. Current systems rely on alterable post-hoc documentation,
Power Integrations Extends Flyback Topology to Enable 440 W, Offering Simpler Alternatives to Resonant Power Designs23.3.2026 22:45:00 CET | Press release
New TOPSwitchGaN ICs more than double power output, reducing system cost, complexity, and design time APEC 2026 – Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today introduced a breakthrough in flyback topology extending the power range of flyback converters to 440 W—well beyond the limits that traditionally required more complex resonant and LLC topologies. The new TOPSwitchGaN™ flyback IC family unites the company’s groundbreaking PowiGaN™ technology with its iconic TOPSwitch™ IC architecture, reducing complexity, eliminating heat sinks in many cases, shortening design time, improving manufacturability, and lowering total system cost. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323686299/en/ The new TOPSwitchGaN™ flyback IC family extends the power range of flyback converters to 440 W—well beyond the limits that traditionally required more co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom